Moomoo AI 已提取核心信息
On January 4, 2024, Cardio Diagnostics Holdings, Inc. and YA II PN, Ltd., an affiliate of Yorkville Advisors Global, LP, mutually agreed to terminate their Securities Purchase Agreement originally dated March 8, 2023. The agreement, which had facilitated the issue and sale of a $5.0 million Convertible Debenture by Cardio Diagnostics to Yorkville, also outlined the conditions for a second Convertible Debenture worth $6.2 million. However, the first debenture has been fully repaid and the obligations for the second debenture have now been nullified with no outstanding borrowings, advance notices, or shares to be issued. The termination of the agreement did not incur any fees for either party.
On January 4, 2024, Cardio Diagnostics Holdings, Inc. and YA II PN, Ltd., an affiliate of Yorkville Advisors Global, LP, mutually agreed to terminate their Securities Purchase Agreement originally dated March 8, 2023. The agreement, which had facilitated the issue and sale of a $5.0 million Convertible Debenture by Cardio Diagnostics to Yorkville, also outlined the conditions for a second Convertible Debenture worth $6.2 million. However, the first debenture has been fully repaid and the obligations for the second debenture have now been nullified with no outstanding borrowings, advance notices, or shares to be issued. The termination of the agreement did not incur any fees for either party.
2024年1月4日，Cardio Diagnostics Holdings, Inc.和Yorkville Advisors Global, Lp的子公司YA II PN, Ltd.共同同意终止其原定于2023年3月8日签订的证券购买协议。该协议为Cardio Diagnostics向约克维尔发行和出售500万美元的可转换债券提供了便利，还概述了第二张价值620万美元的可转换债券的条件。但是，第一张债券已全部偿还，第二张债券的债务现已无效，没有未偿还的借款、预先通知或股票可供发行。协议的终止不会对任何一方产生任何费用。
2024年1月4日，Cardio Diagnostics Holdings, Inc.和Yorkville Advisors Global, Lp的子公司YA II PN, Ltd.共同同意终止其原定于2023年3月8日签订的证券购买协议。该协议为Cardio Diagnostics向约克维尔发行和出售500万美元的可转换债券提供了便利，还概述了第二张价值620万美元的可转换债券的条件。但是，第一张债券已全部偿还，第二张债券的债务现已无效，没有未偿还的借款、预先通知或股票可供发行。协议的终止不会对任何一方产生任何费用。
有用
没用